Postmortem Tryptase Level in 120 Consecutive Nonanaphylactic Deaths: Establishing a Reference Range as <23 μg/L.


Journal

The American journal of forensic medicine and pathology
ISSN: 1533-404X
Titre abrégé: Am J Forensic Med Pathol
Pays: United States
ID NLM: 8108948

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 7 11 2019
medline: 28 11 2019
entrez: 6 11 2019
Statut: ppublish

Résumé

Postmortem tryptase is a useful biochemical test to aid the diagnosis of anaphylaxis. Multiple perimortem and postmortem factors have been documented to cause an elevation in postmortem tryptase level. One factor that was recently recognized to have an impact on postmortem tryptase level is correct sampling technique. A recent study recommended aspirating blood samples from a clamped femoral/external iliac vein to be used for reliable postmortem tryptase analysis. This study sampled 120 consecutive nonanaphylactic deaths in which all the peripheral bloods were sampled as recommended. Postmortem interval, resuscitation, different nonanaphylactic causes of death, sex, and age did not show any statistical significant relation to postmortem tryptase level in Student t test, Pearson correlation, and univariate and multivariate analyses. The mean (SD) postmortem tryptase level was 8.4 (5.2) μg/L (minimum, 1.0 μg/L; maximum, 36.1 μg/L; median, 7.3 μg/L). Using nonparametric methods, the postmortem tryptase reference range in nonanaphylactic death was established as <23 μg/L (97.5th percentile).

Identifiants

pubmed: 31687978
doi: 10.1097/PAF.0000000000000515
doi:

Substances chimiques

Tryptases EC 3.4.21.59

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

351-355

Auteurs

Jack Garland (J)

From the Forensic and Analytical Science Service, NSW Health Pathology, New South Wales, Australia.

Winston Philcox (W)

School of Medicine, Faculty of Medical and Health Sciences, University of Auckland.

Sinead McCarthy (S)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Suneeth Mathew (S)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Sarah Hensby-Bennett (S)

Waikato District Health Board, Hamilton, New Zealand.

Benjamin Ondrushka (B)

Institute of Legal Medicine, University of Leipzig, Leipzig.

Lina Woydt (L)

Institute of Legal Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Ugo Da Broi (U)

Department of Medicine, Section of Forensic Medicine, University of Udine, Udine, Italy.

Cristian Palmiere (C)

CURML, University Center of Legal Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Leo Lam (L)

Departments of Biochemistry.

Yeri Ahn (Y)

Immunopathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Kelly Olds (K)

School of Medicine, University of Notre Dame, Fremantle, Western Australia, Australia.

Charley Glenn (C)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Paul Morrow (P)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Kilak Kesha (K)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Simon Stables (S)

Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Rexson Tse (R)

School of Medicine, Faculty of Medical and Health Sciences, University of Auckland.
Department of Forensic Pathology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH